Proteome Sciences plc (PMSNF)
OTCMKTS
· Delayed Price · Currency is USD
0.0270
-0.0010 (-3.57%)
At close: Apr 3, 2025
Proteome Sciences Revenue
In the year 2024, Proteome Sciences had annual revenue of 4.89M GBP, down -2.80%. Proteome Sciences had revenue of 2.67M in the half year ending December 31, 2024, a decrease of -41.15%.
Revenue
4.89M GBP
Revenue Growth
-2.80%
P/S Ratio
1.77
Revenue / Employee
135.75K GBP
Employees
36
Market Cap
10.84M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
Dec 31, 2020 | 4.75M | 97.00K | 2.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Proteome Sciences News
- 2 months ago - AIM Market Roundup: Proteome Sciences, UKRProduct, Staffline - The Armchair Trader